A phase 2 study of erdafitinib in patients with advanced solid tumors and fibroblast growth factor receptor gene alterations Meeting Abstract
| Authors: | Pant, S.; Tabernero, J.; Massard, C.; Hyman, D. M.; Witt, O.; Doi, T.; Qin, S.; Lu-Emerson, C.; Hargrave, D.; Garcia-Corbacho, J.; Little, S.; Tolbert, J.; Santiago-Walker, A.; Moy, C.; Hammond, C.; Lau, Y. Y.; Sweiti, H.; Schuler, M. |
| Abstract Title: | A phase 2 study of erdafitinib in patients with advanced solid tumors and fibroblast growth factor receptor gene alterations |
| Meeting Title: | 2020 World Conference on Lung Cancer |
| Keywords: | solid tumors; fibroblast growth factor receptor; erdafitinib |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 16 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 28-31 |
| Meeting Location: | Singapore |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-03-01 |
| Start Page: | S673 |
| Language: | English |
| ACCESSION: | WOS:000631349602048 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2021.01.1232 |
| Notes: | Meeting Abstract: P86.03 -- Due to Covid-19 pandemic, the conference was held virtually -- Source: Wos |
